Neurogenic Bladder clinical trials at University of California Health

1 research study open to eligible people

Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder
open to eligible people ages 18-70
The purpose of this study is to evaluate the effectiveness and safety of SCONE neuromodulation therapy after 12 weeks of therapy in comparison to inactive sham control in improving symptoms of Neurogenic Lower Urinary Tract Dysfunction
at UCSD

Last updated: March 2023